Selective Drug Delivery for the Treatment of Other Hepatic Disorders

10 Selective Drug Delivery for the Treatment of Other Hepatic Disorders 

The treatment of tumours in the liver with drug targeting preparations is hampered by the lack of tumour specifity of most preparations. Liposomes incorporating the immunomodula-tor muramyl tripeptide phosphatidylethanolamine have been used as an aspecific approach to increasing the number of tumouricidal macrophages in the liver in order to prevent the development of metastases [99].To date, the greatest tumour cell specificity has been obtained 

4 Cell Specific Delivery of Anti-Inflammatory Drugs to Hepatic Cells 

---